Lutein/omega-3 polyunsaturated fatty acids/zeaxanthin Interactions
There are 77 drugs known to interact with lutein/omega-3 polyunsaturated fatty acids/zeaxanthin, along with 2 disease interactions. Of the total drug interactions, 76 are moderate, and 1 is minor.
- View all 77 medications that may interact with lutein/omega-3 polyunsaturated fatty acids/zeaxanthin
- View lutein/omega-3 polyunsaturated fatty acids/zeaxanthin disease interactions (2)
Most frequently checked interactions
View interaction reports for lutein / omega-3 polyunsaturated fatty acids / zeaxanthin and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aleve (naproxen)
- Aspirin Low Strength (aspirin)
- Astepro Allergy (azelastine nasal)
- B Complex 100 (multivitamin)
- Coenzyme Q10 (ubiquinone)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- D3 (cholecalciferol)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flax Seed Oil (flax)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- Flonase Sensimist (fluticasone nasal)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iron Sulfate (ferrous sulfate)
- Lexapro (escitalopram)
- Metoprolol Succinate ER (metoprolol)
- Mounjaro (tirzepatide)
- NAC (acetylcysteine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Wellbutrin XL (bupropion)
- Zinc (zinc sulfate)
- Zyrtec (cetirizine)
Lutein/omega-3 polyunsaturated fatty acids/zeaxanthin disease interactions
There are 2 disease interactions with lutein / omega-3 polyunsaturated fatty acids / zeaxanthin which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.